Overview

Recent Tweets

Interviews

CEO Edwin Moses of Ablynx in Z-Talk @vegoossens about the differences between Big Pharma and enterpreneurial biotech companies

16 December 2017

Awards

Phase III HERCULES results of caplacizumab in aTTP included in the “Best of ASH” session at the 59th ASH Annual Meeting

Phase III HERCULES results of caplacizumab in aTTP included in the “Best of ASH” session at the 59th ASH Annual Meeting